X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-01 | BLUE | Colvin Richard A | Chief Medical Officer | S - Sale+OE | $1.53 | -6,770 | 118,368 | -5% | -$10,342 | |||||
| D | 2024-03-04 | BLUE | Obenshain Andrew | Pres, CEO | S - Sale+OE | $1.53 | -6,095 | 279,998 | -2% | -$9,311 | |||||
| D | 2024-03-04 | BLUE | Klima Thomas J | See Remarks | S - Sale+OE | $1.53 | -4,573 | 124,840 | -4% | -$6,986 | |||||
2024-02-05 | BLUE | Klima Thomas J | See Remarks | S - Sale | $0.90 | -2,714 | 129,413 | -2% | -$2,449 | ||||||
2024-02-05 | BLUE | Vittiglio Joseph | Chief Business, Legal Officer | S - Sale | $0.90 | -5,217 | 44,783 | -10% | -$4,708 | ||||||
2024-02-05 | BLUE | Obenshain Andrew | Pres, CEO | S - Sale | $0.90 | -1,879 | 286,093 | -1% | -$1,696 | ||||||
2024-01-05 | BLUE | Obenshain Andrew | Pres, CEO | S - Sale | $1.43 | -3,162 | 287,972 | -1% | -$4,520 | ||||||
2024-01-05 | BLUE | Colvin Richard A | Chief Medical Officer | S - Sale | $1.42 | -597 | 125,138 | 0% | -$845 | ||||||
2023-12-06 | BLUE | Krawtschuk Christopher | CFO | S - Sale | $4.52 | -4,526 | 45,474 | -9% | -$20,437 | ||||||
2023-11-03 | BLUE | Obenshain Andrew | Pres, CEO | S - Sale | $3.17 | -807 | 291,134 | 0% | -$2,555 | ||||||
2023-11-02 | BLUE | Colvin Richard A | Chief Medical Officer | S - Sale | $2.98 | -2,343 | 125,735 | -2% | -$6,975 | ||||||
2023-09-05 | BLUE | Klima Thomas J | See Remarks | S - Sale | $3.79 | -922 | 132,127 | -1% | -$3,493 | ||||||
2023-08-10 | BLUE | Obenshain Andrew | Pres, CEO | S - Sale | $3.54 | -16,929 | 291,941 | -5% | -$59,956 | ||||||
2023-06-02 | BLUE | Klima Thomas J | See Remarks | S - Sale | $3.50 | -4,130 | 133,049 | -3% | -$14,451 | ||||||
2022-10-17 | BLUE | Leiderman Elisabeth | Dir | S - Sale | $6.46 | -1,004 | 11,466 | -8% | -$6,490 | ||||||
2023-01-11 | BLUE | Obenshain Andrew | Pres, CEO | S - Sale | $7.80 | -3,178 | 242,690 | -1% | -$24,802 | ||||||
2023-01-11 | BLUE | Colvin Richard A | Chief Medical Officer | S - Sale | $7.80 | -557 | 74,231 | -1% | -$4,347 | ||||||
2023-01-11 | BLUE | Leschly Nick | Dir | S - Sale | $7.80 | -4,290 | 448,848 | -1% | -$33,480 | ||||||
2022-11-04 | BLUE | Colvin Richard A | Chief Medical Officer | S - Sale | $6.41 | -218 | 74,788 | 0% | -$1,398 | ||||||
2022-11-04 | BLUE | Obenshain Andrew | Pres, CEO | S - Sale | $6.41 | -1,263 | 245,868 | -1% | -$8,101 | ||||||
2022-08-19 | BLUE | Cole Jason | Chief Strategy, Financial Off | S - Sale | $5.53 | -14,194 | 189,546 | -7% | -$78,473 | ||||||
2022-08-04 | BLUE | Cole Jason | Chief Strategy, Financial Off | S - Sale | $4.39 | -7,448 | 203,740 | -4% | -$32,707 | ||||||
2022-08-04 | BLUE | Obenshain Andrew | Pres, CEO | S - Sale | $4.39 | -21,805 | 247,131 | -8% | -$95,754 | ||||||
2022-07-12 | BLUE | Eggimann Anne-Virginie | Chief Regulatory Officer | S - Sale | $4.95 | -1,358 | 42,252 | -3% | -$6,722 | ||||||
2022-06-03 | BLUE | Klima Thomas J | Chief Commercial Officer | S - Sale | $3.07 | -3,753 | 71,439 | -5% | -$11,535 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |